Nutrafol is the fastest growing nutraceutical supplement for healthy hair growth for men and women, and has now closed its series A financing round.
Unilever Ventures, the venture-capital and private-equity arm of consumer packaged goods conglomerate, joins as lead investor after an initial introduction from investment platform CircleUp.
"Up until now, physicians have had very few, if any, healthy options to offer patients concerned with poor hair health," says Nutrafol's president, Roland Peralta. "Our researchers created an award-winning solution that fills the void by providing the medical community a healthy and effective option, without side effects, for their patients in the treatment of poor hair health."
"By leveraging the latest discoveries in hair research and biotechnology, we reverse engineered a formulation to target many underlying causes of hair loss, which our competitors fail to address," remarks Giorgos Tsetis, C.E., the CEO of Nutrafol.
"We now know poor hair health is due to an accumulation of causes, including stress, inflammation and hormonal imbalances. We live in a time when these causes, particularly stress, are on the rise in modern society, which explains why hair loss is a global epidemic. It's a multibillion dollar category with a double digit compounded annual growth rate (CAGR) projected in the coming years, making this a very lucrative opportunity for our investors."
"Hair loss is a global issue affecting millions of men and women every day. The founding team at Nutrafol, a nutraceutical supplement, has done a phenomenal job disrupting the status quo of the hair loss industry by shifting the paradigm in how western medicine talks about hair loss," says Stephen Willson, Investment Director, Unilever Ventures. "Consumers are demanding natural solutions that work- the high trajectory growth of the brand is indicative that Nutrafol is on the frontier of that."